1. Home
  2. RGNX vs RRBI Comparison

RGNX vs RRBI Comparison

Compare RGNX & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • RRBI
  • Stock Information
  • Founded
  • RGNX 2008
  • RRBI 1998
  • Country
  • RGNX United States
  • RRBI United States
  • Employees
  • RGNX N/A
  • RRBI N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • RRBI Hotels/Resorts
  • Sector
  • RGNX Health Care
  • RRBI Consumer Discretionary
  • Exchange
  • RGNX Nasdaq
  • RRBI Nasdaq
  • Market Cap
  • RGNX 445.5M
  • RRBI 406.6M
  • IPO Year
  • RGNX 2015
  • RRBI 2019
  • Fundamental
  • Price
  • RGNX $8.82
  • RRBI $66.23
  • Analyst Decision
  • RGNX Strong Buy
  • RRBI Buy
  • Analyst Count
  • RGNX 8
  • RRBI 1
  • Target Price
  • RGNX $28.50
  • RRBI $67.00
  • AVG Volume (30 Days)
  • RGNX 687.5K
  • RRBI 10.8K
  • Earning Date
  • RGNX 08-07-2025
  • RRBI 07-30-2025
  • Dividend Yield
  • RGNX N/A
  • RRBI 0.73%
  • EPS Growth
  • RGNX N/A
  • RRBI 23.60
  • EPS
  • RGNX N/A
  • RRBI 5.67
  • Revenue
  • RGNX $155,782,000.00
  • RRBI $115,623,000.00
  • Revenue This Year
  • RGNX $327.08
  • RRBI $5.20
  • Revenue Next Year
  • RGNX N/A
  • RRBI $17.47
  • P/E Ratio
  • RGNX N/A
  • RRBI $11.58
  • Revenue Growth
  • RGNX 74.95
  • RRBI 10.19
  • 52 Week Low
  • RGNX $5.04
  • RRBI $46.33
  • 52 Week High
  • RGNX $13.48
  • RRBI $66.40
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 53.29
  • RRBI 65.37
  • Support Level
  • RGNX $7.83
  • RRBI $61.25
  • Resistance Level
  • RGNX $9.24
  • RRBI $66.40
  • Average True Range (ATR)
  • RGNX 0.51
  • RRBI 1.47
  • MACD
  • RGNX 0.08
  • RRBI 0.32
  • Stochastic Oscillator
  • RGNX 77.37
  • RRBI 96.86

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About RRBI Red River Bancshares Inc.

Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.

Share on Social Networks: